Lupin Gets USFDA Approval for Generic Pulmonary Hypertension Drug

By By Rediff Money Desk, NEWDELHI
Nov 02, 2023 14:19
Lupin receives USFDA approval to market generic Selexipag for injection, a treatment for pulmonary arterial hypertension. The drug will be manufactured at the company's Nagpur facility.
New Delhi, Nov 2 (PTI) Drug maker Lupin on Thursday said it has received approval from the US health regulator to market generic medication to treat pulmonary arterial hypertension.

It has received tentative approval from the US Food and Drug Administration (USFDA) for Selexipag for injection, Lupin said in a regulatory filing.

The company's product is a generic version of Actelion Pharmaceuticals US, Inc.'s Uptravi for injection.

Lupin said the product would be manufactured at its Nagpur facility.

The product sales for Selexipag franchise in the US stood at USD 1,104 million for the year ended December 2022.
Read More On:
lupinusfdageneric medicationpulmonary arterial hypertensionselexipag
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

NAFED Urad Procurement in UP: 50 Centers Open

NAFED to open 50 urad procurement centers in 17 UP districts. Farmers can sell at MSP...

NCLAT Asks Renewal of Bank Guarantee for IL&FS...

NCLAT directs Brookfield-backed Chronos to renew bank guarantee for acquiring IL&FS...

SBI Reduces Lending Rate After RBI Cut

SBI cuts lending rate by 25 bps after RBI rate cut. Loans become cheaper for borrowers....

Pakistan & Binance Pact: Tokenisation of Assets

Pakistan and Binance sign MoU for tokenisation of assets up to USD 2 billion. Boost...

IndiGo Seeks Rs 900 Cr Customs Duty Refund in...

IndiGo moves Delhi HC for Rs 900 crore Customs duty refund on re-imported aircraft...

Sebi Clears Pranav Adani in Insider Trading Case

Sebi clears Pranav Adani, Adani Group director, of insider trading charges related to...

Sebi Officials & Asset Disclosure: Privacy...

Sebi officials express privacy concerns over public asset disclosure. Pandey discusses...

New Labour Codes: Supply Chains, Wages, Skilling

New Labour Codes in India aim for frictionless supply chains, universal wage coverage,...

Fidelity Buys 6.3% Stake in Meesho

Fidelity International acquires a 6.3% stake in e-commerce firm Meesho. The stake is...

Wipro & Google Cloud Deploy Gemini AI

Wipro expands Google Cloud partnership to deploy Gemini AI across operations. Jointly...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com